The Early Detection Research Group (EDRG) supports research that seeks to determine the effectiveness, operating characteristics, and clinical impact (harms as well as benefits) of cancer early detection technologies and practices, such as imaging and molecular biomarker approaches.
Read more About the Early Detection Research Group.
News and Events
An Improved Prostate Cancer Biomarker Test May Help Men Avoid Unnecessary Biopsy
Date Posted: April 29, 2024
DCP Participation at American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024
Date Posted: March 12, 2024
NIH Launches Research Network to Evaluate Emerging Cancer Screening Technologies
Date Posted: February 21, 2024
Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up
Date Posted: December 22, 2023